Register Here

Executive Sponsors

Cofactor Genomics
Covance
ERT
Fate Therapeutics
Imaging Endpoints
Iovance
IQVIA
Mitra Biotech
NeoGenomics
Parexel
Q2 Solutions

Associate Sponsors

Cello Health BioConsulting
Medidata

Exhibitors

Caprion
Myriad

Supporting & Educational Partners

Alliance for Regenerative Medicine (ARM)
California Life Sciences Association (CLSA)
Cancer Research Institute CRI
Center for Biotechnology (CFB)
Journal of Immunotherapy and Precision Oncology (JIPO)
Society for Immunotherapy of Cancer (SITC)

Media Partners

Big4Bio
CIMT
Clinical trial vendors
Gene Therapy Net
Life Science Leader
MedTech Outlook

Reporting on the Latest Cell & Gene Therapy Progress with a Focus on Solid Tumors

The cell and gene therapy field for cancer immunotherapy has seen major success over the past year with landmark approvals and regression in cancers of the blood. However, translating that success into solid tumors has been quite challenging. 

Cell & Gene Therapy Day convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies.

Cell & Gene Therapy Day Delivers Three Key Benefits:

  1. Access to KOLs driving the science
  2. Partnership opportunities with all stakeholders in cell and gene therapy
  3. Presentations on the latest data affecting the science, clinical and business advancements in cell and gene therapy

 

2020 Featured Speakers

 

Key Topic Areas: 

  • Landscape and Evolution to Marketplace: Progress
  • New Scientific Frontiers in Cell Therapies for Solid Tumors
  • Cell Therapy Pivotal Developments for Solid Tumors
  • Current and Future Innovations Toward GMP Manufacturing of CAR and TCR Engineered T Cells
  • FDA Led Session on the Evolution of Regulatory Policy for Cell & Gene Therapy

Cell & Gene Therapy Day is available as an independent one day program with a luncheon and networking reception or attendees can register for the three day IO360˚ program, which includes the Cell & Gene Therapy day. For more information on IO360˚, please click here.

Please contact us at service@tcfllc.org if you have any questions. Thank you.

Sincerely,​

kate-bw-3

Kate Woda
Conference Director

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Business Development

geeta-new-bw

Geeta Bachani
Business Development Manager

elizabeth-bard-bw-2

Elizabeth Bard
Business Development Manager

Bre Bugbee
Marketing Manager

Adam Kolanko
Business Development Manager

Meg

Meg Gould
Senior Conference Planner

Efrosini Zambas
Conference Meeting Planner